197 related articles for article (PubMed ID: 21182493)
1. Elucidation of flow-mediated tumour cell-induced platelet aggregation using an ultrasound standing wave trap.
Bazou D; Santos-Martinez MJ; Medina C; Radomski MW
Br J Pharmacol; 2011 Apr; 162(7):1577-89. PubMed ID: 21182493
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
Jurasz P; Sawicki G; Duszyk M; Sawicka J; Miranda C; Mayers I; Radomski MW
Cancer Res; 2001 Jan; 61(1):376-82. PubMed ID: 11196190
[TBL] [Abstract][Full Text] [Related]
3. Differential inhibition of tumour cell-induced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin.
Medina C; Harmon S; Inkielewicz I; Santos-Martinez MJ; Jones M; Cantwell P; Bazou D; Ledwidge M; Radomski MW; Gilmer JF
Br J Pharmacol; 2012 Jun; 166(3):938-49. PubMed ID: 22122360
[TBL] [Abstract][Full Text] [Related]
4. Platelet aggregation-induced by caco-2 cells: regulation by matrix metalloproteinase-2 and adenosine diphosphate.
Medina C; Jurasz P; Santos-Martinez MJ; Jeong SS; Mitsky T; Chen R; Radomski MW
J Pharmacol Exp Ther; 2006 May; 317(2):739-45. PubMed ID: 16424148
[TBL] [Abstract][Full Text] [Related]
5. Role of von Willebrand factor in tumour cell-induced platelet aggregation: differential regulation by NO and prostacyclin.
Jurasz P; Stewart MW; Radomski A; Khadour F; Duszyk M; Radomski MW
Br J Pharmacol; 2001 Nov; 134(5):1104-12. PubMed ID: 11682459
[TBL] [Abstract][Full Text] [Related]
6. Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins.
Alonso-Escolano D; Strongin AY; Chung AW; Deryugina EI; Radomski MW
Br J Pharmacol; 2004 Jan; 141(2):241-52. PubMed ID: 14691052
[TBL] [Abstract][Full Text] [Related]
7. Studies on tumor-cell-induced platelet aggregation in human lung cancer cell lines.
Heinmöller E; Weinel RJ; Heidtmann HH; Salge U; Seitz R; Schmitz I; Müller KM; Zirngibl H
J Cancer Res Clin Oncol; 1996; 122(12):735-44. PubMed ID: 8954171
[TBL] [Abstract][Full Text] [Related]
8. Characterization of platelet aggregation induced by human colon adenocarcinoma cells and its inhibition by snake venom peptides, trigramin and rhodostomin.
Chiang HS; Swaim MW; Huang TF
Br J Haematol; 1994 Jun; 87(2):325-31. PubMed ID: 7947275
[TBL] [Abstract][Full Text] [Related]
9. Influence of aflibercept on platelet activation profile.
Sobolewska B; Golenko J; Poeschel S; Grimmel C; Gatsiou A; Sopova K; Biedermann T; Schenke-Layland K; Stellos K; Ziemssen F
Exp Eye Res; 2018 Oct; 175():166-172. PubMed ID: 29908884
[TBL] [Abstract][Full Text] [Related]
10. Release of gelatinase A during platelet activation mediates aggregation.
Sawicki G; Salas E; Murat J; Miszta-Lane H; Radomski MW
Nature; 1997 Apr; 386(6625):616-9. PubMed ID: 9121586
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of platelet aggregation induced by PC-3 human prostate adenocarcinoma cells and inhibited by venom peptides, trigramin and rhodostomin.
Swaim MW; Chiang HS; Huang TF
Eur J Cancer; 1996 Apr; 32A(4):715-21. PubMed ID: 8695278
[TBL] [Abstract][Full Text] [Related]
12. Triflavin, an Arg-Gly-Asp containing snake venom peptide, inhibits aggregation of human platelets induced by human hepatoma cell line.
Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
Thromb Res; 1992 Jun; 66(6):679-91. PubMed ID: 1519227
[TBL] [Abstract][Full Text] [Related]
13. Thrombin promotes platelet-mediated melanoma cell adhesion to endothelial cells under flow conditions: role of platelet glycoproteins P-selectin and GPIIb-IIIA.
Dardik R; Savion N; Kaufmann Y; Varon D
Br J Cancer; 1998 Jun; 77(12):2069-75. PubMed ID: 9649116
[TBL] [Abstract][Full Text] [Related]
14. Effect of low concentration of epinephrine on human platelet aggregation analyzed by particle counting method and confocal microscopy.
Nakamura T; Ariyoshi H; Kambayashi J; Ikeda M; Kawasaki T; Sakon M; Monden M
J Lab Clin Med; 1997 Sep; 130(3):262-70. PubMed ID: 9341985
[TBL] [Abstract][Full Text] [Related]
15. Platelet--cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation.
Jurasz P; Alonso-Escolano D; Radomski MW
Br J Pharmacol; 2004 Dec; 143(7):819-26. PubMed ID: 15492016
[TBL] [Abstract][Full Text] [Related]
16. Characterization of platelet aggregation induced by human breast carcinoma and its inhibition by snake venom peptides, trigramin and rhodostomin.
Chiang HS; Swaim MW; Huang TF
Breast Cancer Res Treat; 1995 Mar; 33(3):225-35. PubMed ID: 7749150
[TBL] [Abstract][Full Text] [Related]
17. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
[TBL] [Abstract][Full Text] [Related]
18. The immunoregulatory glycan-binding protein galectin-1 triggers human platelet activation.
Pacienza N; Pozner RG; Bianco GA; D'Atri LP; Croci DO; Negrotto S; Malaver E; Gómez RM; Rabinovich GA; Schattner M
FASEB J; 2008 Apr; 22(4):1113-23. PubMed ID: 17984174
[TBL] [Abstract][Full Text] [Related]
19. Activation and shedding of platelet glycoprotein IIb/IIIa under non-physiological shear stress.
Chen Z; Mondal NK; Ding J; Koenig SC; Slaughter MS; Griffith BP; Wu ZJ
Mol Cell Biochem; 2015 Nov; 409(1-2):93-101. PubMed ID: 26160282
[TBL] [Abstract][Full Text] [Related]
20. P-selectin expression on platelets determines size and stability of platelet aggregates.
Merten M; Thiagarajan P
Circulation; 2000 Oct; 102(16):1931-6. PubMed ID: 11034941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
